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Abstract 
 
Objectives: Paraoxanase 1 (PON1) plays a protective role against the oxidative modification of plasma lipoproteins and 
hydrolyzes lipid peroxides in human atherosclerotic lesions. Cumin is the dried seed of the herb Cuminumcyminum that is 
known as Zeera in Iran. Cumin seeds contain flavonoids which are now generally recognized to have antioxidant activity and 
improve the antioxidant system. So, they possibly modify PON1 activity and oxidized low density lipoprotein (oxLDL) level. The 
present study was aimed to evaluate the effects of cumin extract supplementation on oxLDL, paraoxanase 1 activity, FBS, total 
cholesterol, triglycerides, High density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), 
apolipoprotein A1 (Apo A1), and apolipoprotein B (Apo B)in the patients with hypercholesterolemia. 
 
Methodology: A fasting venous blood sample was obtained from the voluntary persons before and 45±3 days after taking 
cumin. Glucose, total cholesterol, and triglycerides were assayed using standard enzymatic procedures. HDL-Cand LDL-C were 
measured by direct method and ApoA1 and ApoB levels by immunoturbidimeteric methods. The levels of arylesterase and 
paraoxanase activities in the samples were measured by photometry methods and oxLDL by enzyme-linked immunosorbent 
assay (ELISA) method. 3 to 5 drops of cumin extract were added to the patient's diet three times a day based on manufacturer’s 
instruction for 45±3 days. The biochemical parameters were compared before and after taking cumin. Data were analyzed using 
paired Student’s t-test in SPSS statistical software (version 11.5). 
 
Results: The results demonstrated that there was a significant decrease in the level of oxLDL after receiving cumin. 
Paraoxonase and arylesterase activities increased in serum after taking cumin extract.   
 
Conclusion: Based on the results, cumin reduces oxLDL level and increases both paraoxonase and arylesterase activity. 
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Introduction 
     Cumin has long been used as a medicinal 
plant. In diabetic animals, cumin decreases 
serum glucose levels. It causes bile acid and 
pancreatic enzymes to secrete in laboratory 
animals. Cumin oil demonstrated antimicrobial 
activity in laboratory tests. (1)  Main constituent 
and important aroma compound of cumin is 
cuminaldehyde (4-isopropyl benzaldehyde). (2) 
Cumin seeds have flavonoids, which are 
generally known for their antioxidant activity. (3, 
4) Foods rich in natural antioxidants play an 
essential role in the prevention of 
cardiovascular diseases and cancer. 
Antioxidants are often added to foods to 
prevent the radical chain reactions of oxidation 
and to inhibit the initiation and propagation 
steps, consequently delaying the oxidation 
process. (5) 
     Cumin has significant inhibitory effects on 
lipid peroxidation which is measured as 
formation of malondialdehyde (MDA) 
production. Significant elevation of the specific 
activities of superoxide dismutase and catalase 
was reported in the antioxidant system after 
cumin taking. (6) 
     Oxidized low density lipoprotein (oxLDL) 
plays an important role in the development of 
atherosclerosis. High density lipoprotein (HDL) 
plays anti atherogenesis and anti coronary 
heart disease roles. (7) HDLs as carriers of 
enzymes destroy the lipid hydroperoxides that, 
in turn, contribute to low density lipoprotein 
(LDL) phospholipids oxidization. Serum 
concentration of apolipoprotein A1 (ApoA1), 
which covers the HDL particle, reflects the 
number of anti atherogenic particles. (8) 
apolipoprotein B (Apo B) is the structural 
protein of atherogenic lipoproteins, including 
very low density lipoprotein (VLDL), 
intermediate density lipoprotein (IDL), and 
LDL. (9) Human paraoxonase-1 (PON1) is 
associated with HDL particles (10) and the 
antioxidant activity of HDL is largely due to the 
activity of PON1. Previous studies indicated 
that PON1 played a protective role against the 
oxidative modification of plasma lipoproteins 
and hydrolyzed lipid peroxides in human 
atherosclerotic lesions. (11, 12) The present work 
aims to show the effects of cumin extract 
supplementation on oxLDL, paraoxanase 1 
activity, FBS, total cholesterol, triglycerides, 
HDL cholesterol (HDL-C), LDL cholesterol 
(LDL-C), Apo A1, and Apo B in the patients 
with hypercholesterolemia. 
 
Materials and Methods 
 
Patients 
     This study was conducted from April to 
August 2010. 39 patients with LDL-C between 
100 to 185 mg/dl referred to a clinic of internal 
medicine in Shahrekord, Iran were enrolled. 
None of the patients were taking lipid-lowering 
drugs or any other medication known to affect 
lipid metabolism before and during the study. 
The individuals with hypertension, diabetes 
mellitus, thyroid, hepatic and renal diseases, 
and smokers were excluded from the study. A 
consent form was filled out by the patients and 
the study’s whole procedure was approved by 
the Ethics Committee of Shahrekord University 
of Medical Sciences (Ethics Code: 87-10-1).  3 
to 5 drops of cumin extract (Zardband 
Pharmaceutical Company, Iran) were added to 
the patient's diet three times a day based on 
manufacturer’s instruction for 45±3 days.  
 
Biochemical analysis 
     A fasting blood sample was obtained from 
the patients before onset of receiving cumin. 
The second blood sample was taken 45±3 
days after the end of the treatment. Glucose, 
total cholesterol (TC), and triglycerides (TG) 
were assayed using standard enzymatic 
procedures. HDL-C and LDL-C were measured 
by direct method and ApoA1 and ApoB levels 
by immunoturbidimeteric methods. Creatinine 
was measured by Jaffe method (13) to exclude 
renal patients. All biochemical tests were 
measured in serum on BT 3000 automatic 
analyzer by commercial kits (Pars Azmoon, 
Iran). Arylesterase activity was measured 
using phenylacetate as the substrate according 
to the modified procedure of Kitchen et al. (14) 
PON1 activity toward paraoxon was measured 
after the reaction of paraoxon hydrolysis into p-
nitrophenol and diethylphosphate catalyzed by 
the enzyme. (15) The oxLDL was measured by 
a sandwich ELISA method using commercial 
kit (Mercodia-Sweden). The quantitative 
variables were analyzed using paired Student’s 
t-test (SPSS 11.5) and p value was considered 
significant when < 0.05.  
 
Results 
     All patients fulfilled the process of the study 
and there were no dropouts. The patients’ 
demographic characteristics are summarized 
in Table 1.
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Table 1. The patients’ demographic characteristics 
Cumin  group (39) Variable 
10.5±48  
48.7  
3.8±25 
Age  
Male )%(  
BMI 
 
The biochemical parameters including Fasting 
Blood Sugar (FBS), Body Mass Index (BMI), 
lipid profile, oxLDL, and PON1 enzymes 
activity were compared before and after taking 
cumin. Arylesterase activity and paraoxonase 
activity were increased by cumin. FBS and 
oxLDL decreased after cumin taking. 
Considering other parameters, no significant 
difference was seen between before and after 
taking cumin (Table 2). 
 
Table 2. The biochemical variables before and after receiving cumin 
Variable Before receiving 
Cumin 
After receiving 
cumin 
P 
value 
BMI1 
FBS2 (mg/dl) 
Total cholesterol (mg/dl) 
)mg/dl (Triglycerides 
)mg/dl (HDL-C3 
)mg/dl (LDL-C4  
)mg/dl (ApoA15 
)mg/dl (ApoB6  
)u/L (oxLDL7  
PON18arylesterase activity  
PON1 paraxonase activity 
3.8±25 
15.5±97 
50.5±215  
175±274  
10.5±45  
43.3±139  
26.6±141  
19.1±116  
14.7±85  
32.5±90  
185+101 
3.9±25 
10.5±90 
45.6±214  
161±259  
10.2±42  
47.5±134 
25.5±145  
18.2±117  
12.9±76  
38.7±104  
235+143 
0.33 
0.04 
0.35 
0. 21 
0.42 
0.51  
0.12 
0.26 
0.01 
0.04 
0.01 
1. body mass index; 2. fasting blood sugar; 3. high density lipoprotein cholesterol; 4. low density lipoprotein cholesterol;  
5.apolipoprotein A1; 6. apolipoprotein B; 7. oxidized low density lipoprotein; 8. paraoxanase 1. 
 
Table 3. The biochemical variables before and after receiving cumin 
Total(n=39)  Female(n=20)  Male(n=19)    
P value  
After 
receiving 
cumin  
Before 
receiving 
Cumin  
P value  
After 
receiving 
cumin  
Before 
receiving 
Cumin  
P 
value  
After 
receiving 
cumin  
Before 
receiving 
Cumin  
Variable 
0.33 3.9±25 3.8±25 0.41  5.1±24  3.9±24  0.21  5.4±25  4.3±26  BMI1 
0.04 10.5±90 15.5±97 0.03  15.2±80  14.1±88  0.60  12.7±94  16.5±99  FBS2 (mg/dl) 
0.35 45.6±214  50.5±215  0.55  44±199  39±204  0.39  47±221  56±219  Total cholesterol (mg/dl) 
0. 21 161±259  175±274  0.66  177±257  161±264  0.70  166±273  195±281   )mg/dl(Triglycerides  
0.42 10.2±42  10.5±45  0.38  10.2±45  11.4±49  0.49  9.8±43  10.5±41  )mg/dl (HDL-C3 
0.51  47.5±134 43.3±139  0.43  46.5±132   41±137  0.45  49.7±140   45.2± 141  )mg/dl (LDL-C4  
0.12 25.5±145  26.6±141  0.18  26±152  24.1±149  0.15  26.4±140   33.3±138  )mg/dl (ApoA15 
0.26 18.2±117  19.1±116  0.19  19±106  17.5±111  0.31  18.9±124   22±123  )mg/dl (ApoB6  
0.01 12.9±76  14.7±85  0.01  10.5±63  16.1±79  0.02  13.5±82  15.2±91  )u/L (oxLDL7  
0.04 38.7±104  32.5±90  0.03  36.7±96  33±81  0.02   41.8±121   28.9±97  
PON18 arylesterase 
activity  
0.01 235+143 185+101 0.01  93±231  77.9±183  0.01  155±245   122.1±187  PON1 paraxonase activity 
1. body mass index; 2. fasting blood sugar; 3. high density lipoprotein cholesterol; 4. low density lipoprotein cholesterol;  5. 
apolipoprotein A1; 6. apolipoprotein B; 7. oxidized low density lipoprotein; 8. paraoxanase 1. 
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Discussion  
     PON1 activity can be mediated by factors 
including diet (16) and anti oxidant intake. PON1 
also was found to be inactivated by oxidized 
lipids and oxLDL, (17) hence oxLDL reduction 
may lead to increase in PON1 activity that was 
seen in this study. 
     PON1 could be a major defense barrier 
against lipid peroxides. Many studies strongly 
supported the hypothesis that oxidative 
modification of LDL contributes greatly to the 
pathogenesis of atherosclerosis. Arylesterase 
activity has direct correlation with mass of this 
enzyme protein (18) and serum paraoxanase 
activity seems most closely related to the 
inverse relationship with coronary heart 
disease. (19) 
     Reduction of toxicity of thermally oxidized 
sunflower's oil was reported in a study on 
animals following feeding with cumin. (20) This 
protective effect may be due to reduction of 
oxidized lipids such as oxLDL or activation of 
some enzymes that have antioxidant property 
and lead to oxidized lipids destruction. 
     Reduction of oxLDL in our study may be 
due to the antioxidant effects of cumin. Cumin 
is a rich source of flavonoids (4) and 
cuminaldehyde (3) that have been reported as 
antioxidant substances; therefore, oxLDL level 
could be decreased by these compounds. (21)  
     Studies on anticancer properties of cumin 
showed that free radical was scavenged by 
cumin's materials. (7, 21) So, free radical 
reduction may lead to reduction of oxLDL that 
was seen in this study. 
     Manganese and zinc are rich in cumin. (22) 
Manganese can activate superoxide 
dismutase; an enzyme which destroys 
superoxide anion protects lipids from oxidation. 
Cholesterol level did not decrease after cumin 
extract taking in this study, that is in agreement 
with a study on animals (23) but not consistent 
with some reports. (24, 25) 
     In this study, we observed that the cumin 
reduced FBS and could be suggested for 
diabetes treatment. Cumin seeds could cause 
hypoglycaemia. (26)  An aqueous extract of 
cumin can lower the blood glucose, and 
plasma and tissue lipids in alloxan diabetic 
rats. (25) 
 
Conclusion 
     In this study, cumin reduced oxLDL level 
and increased PON1 paraoxanase and 
arylesterase activity. 
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